Skip to main content
Erschienen in: Obesity Surgery 1/2011

01.01.2011 | Clinical Research

Dehydroepiandrosterone-Sulfate Modifies Human Fatty Acid Composition of Different Adipose Tissue Depots

verfasst von: Juan Jose Hernandez-Morante, David Cerezo, Rosa Maria Cruz, Elvira Larque, Salvador Zamora, Marta Garaulet

Erschienen in: Obesity Surgery | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Dehydroepiandrosterone-sulfate (DHEA-S) has been described as a protector agent against obesity-related pathologies, although the mechanism of action is still unknown. We have shown that DHEA-S acts on adipose tissue (AT), altering the fatty acid (FA) profile in rodents. Thus, we could hypothesize that some of the beneficial effects shown by DHEA-S in humans are related to a modification of the human AT-FA profile. The present study examines this question and whether this effect is tissue-dependent.

Methods

Paired visceral and subcutaneous AT biopsies were obtained from 20 patients who had undergone bariatric surgery. These samples were subjected to primary adipose culture and incubated for 24 h with 1 μM DHEA-S. The FA profile of both control and treated samples were analyzed by gas chromatography.

Results

A reduction in total saturated fatty acids (SFA), the n−6 family of polyunsaturated fatty acids (PUFA) and the n−6/n−3 PUFA ratio was observed after DHEA-S treatment, whereas monounsaturated fatty acids (MUFA) increased. In addition, DHEA-S altered the percentage of several individual FA, decreasing palmitic acid and increasing vaccenic acid in both AT. All estimated desaturase activity ratios slightly increased after DHEA-S treatment, although only the increase of delta-6-desaturase index in both depots reached statistical significance. No depot-specific action of DHEA-S was found between subcutaneous and visceral AT.

Conclusions

In vitro, DHEA-S modifies the AT-FA composition towards a better metabolic profile to a similar extent in the subcutaneous and visceral adipose depots, in both of which a decrease in SFA and increased MUFA are observed after treatment. This effect could help to explain the beneficial effects attributed to DHEA-S. Further studies, however, are required to determine whether the effect of DHEA-S on adipose tissue in vitro is conserved in vivo.
Literatur
1.
Zurück zum Zitat Aoki K, Nakajima A, Mukasa K, et al. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone. J Steroid Biochem Mol Biol. 2003;85:469–72.CrossRefPubMed Aoki K, Nakajima A, Mukasa K, et al. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone. J Steroid Biochem Mol Biol. 2003;85:469–72.CrossRefPubMed
2.
Zurück zum Zitat Valle LD, Toffolo V, Nardi A, et al. Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue. J Endocrinol. 2006;190:129–39.CrossRefPubMed Valle LD, Toffolo V, Nardi A, et al. Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue. J Endocrinol. 2006;190:129–39.CrossRefPubMed
3.
Zurück zum Zitat Komesaroff PA. Unravelling the enigma of dehydroepiandrosterone: moving forward step by step. Endocrinology. 2008;149:886–8.CrossRefPubMed Komesaroff PA. Unravelling the enigma of dehydroepiandrosterone: moving forward step by step. Endocrinology. 2008;149:886–8.CrossRefPubMed
4.
Zurück zum Zitat Labrie F, Luu-The V, Labrie C, et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol. 2001;22:185–212.CrossRefPubMed Labrie F, Luu-The V, Labrie C, et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol. 2001;22:185–212.CrossRefPubMed
5.
Zurück zum Zitat Liu D, Iruthayanathan M, Homan LL, et al. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology. 2008;149:889–98.CrossRefPubMed Liu D, Iruthayanathan M, Homan LL, et al. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology. 2008;149:889–98.CrossRefPubMed
6.
Zurück zum Zitat Liu D, Ren M, Bing X, et al. Dehydroepiandrosterone inhibits intracellular calcium release in beta-cells by a plasma membrane-dependent mechanism. Steroids. 2006;71:691–9.CrossRefPubMed Liu D, Ren M, Bing X, et al. Dehydroepiandrosterone inhibits intracellular calcium release in beta-cells by a plasma membrane-dependent mechanism. Steroids. 2006;71:691–9.CrossRefPubMed
7.
Zurück zum Zitat Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids. 2004;69:279–89.CrossRefPubMed Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids. 2004;69:279–89.CrossRefPubMed
8.
Zurück zum Zitat Bird CE, Masters V, Clark AF. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med. 1984;7:119–22.PubMed Bird CE, Masters V, Clark AF. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med. 1984;7:119–22.PubMed
9.
Zurück zum Zitat Yamaguchi Y, Tanaka S, Yamakawa T, et al. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol (Oxf). 1998;49:377–83.CrossRef Yamaguchi Y, Tanaka S, Yamakawa T, et al. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol (Oxf). 1998;49:377–83.CrossRef
10.
Zurück zum Zitat Kawai S, Yahata N, Nishida S, et al. Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation. Anticancer Res. 1995;15:427–31.PubMed Kawai S, Yahata N, Nishida S, et al. Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation. Anticancer Res. 1995;15:427–31.PubMed
11.
Zurück zum Zitat Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988;66:57–61.CrossRefPubMed Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988;66:57–61.CrossRefPubMed
12.
Zurück zum Zitat Lea-Currie YR, Wen P, McIntosh MK. Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high-fat diet. Int J Obes Relat Metab Disord. 1997;21:1058–64.CrossRefPubMed Lea-Currie YR, Wen P, McIntosh MK. Dehydroepiandrosterone-sulfate (DHEAS) reduces adipocyte hyperplasia associated with feeding rats a high-fat diet. Int J Obes Relat Metab Disord. 1997;21:1058–64.CrossRefPubMed
13.
Zurück zum Zitat Garaulet M, Pérez-Llamas F, Fuente T, et al. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol. 2000;143:657–66.CrossRefPubMed Garaulet M, Pérez-Llamas F, Fuente T, et al. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol. 2000;143:657–66.CrossRefPubMed
14.
Zurück zum Zitat Pritchard J, Després JP, Gagnon J, et al. Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins. J Clin Endocrinol Metab. 1998;83:3277–84.CrossRefPubMed Pritchard J, Després JP, Gagnon J, et al. Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins. J Clin Endocrinol Metab. 1998;83:3277–84.CrossRefPubMed
15.
Zurück zum Zitat Imai K, Kudo N, Koyama M, et al. Effects of dehydroepiandrosterone on oleic acid accumulation in rat liver. Biochem Pharmacol. 2003;65:1583–91.CrossRefPubMed Imai K, Kudo N, Koyama M, et al. Effects of dehydroepiandrosterone on oleic acid accumulation in rat liver. Biochem Pharmacol. 2003;65:1583–91.CrossRefPubMed
16.
Zurück zum Zitat de Heredia FP, Larqué E, Zamora S, et al. Dehydroepiandrosterone modifies rat fatty acid composition of serum and different adipose tissue depots and lowers serum insulin levels. J Endocrinol. 2009;201:67–74.CrossRefPubMed de Heredia FP, Larqué E, Zamora S, et al. Dehydroepiandrosterone modifies rat fatty acid composition of serum and different adipose tissue depots and lowers serum insulin levels. J Endocrinol. 2009;201:67–74.CrossRefPubMed
17.
Zurück zum Zitat Seidelin KN. Fatty acid composition of adipose tissue in humans. Implications for the dietary fat-serum cholesterol-CHD issue. Prog Lipid Res. 1995;34:199–217.CrossRefPubMed Seidelin KN. Fatty acid composition of adipose tissue in humans. Implications for the dietary fat-serum cholesterol-CHD issue. Prog Lipid Res. 1995;34:199–217.CrossRefPubMed
18.
Zurück zum Zitat Garaulet M, Pérez-Llamas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74:585–91.PubMed Garaulet M, Pérez-Llamas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74:585–91.PubMed
19.
Zurück zum Zitat Salas-Salvadó J, Rubio MA, Barbany M, et al. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria [article in Spanish. Med Clin (Barc). 2007;128:184–96.CrossRef Salas-Salvadó J, Rubio MA, Barbany M, et al. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria [article in Spanish. Med Clin (Barc). 2007;128:184–96.CrossRef
20.
Zurück zum Zitat Ritchie JD, Miller CK, Smiciklas-Wright H. Tanita foot-to-foot bioelectrical impedance analysis system validated in older adults. J Am Diet Assoc. 2005;105:1617–9.CrossRefPubMed Ritchie JD, Miller CK, Smiciklas-Wright H. Tanita foot-to-foot bioelectrical impedance analysis system validated in older adults. J Am Diet Assoc. 2005;105:1617–9.CrossRefPubMed
21.
Zurück zum Zitat Ruano M, Silvestre V, Castro R, et al. HOMA, QUICKI and MFfm to measure insulin resistance in morbid obesity. Obes Surg. 2006;16:549–53.CrossRefPubMed Ruano M, Silvestre V, Castro R, et al. HOMA, QUICKI and MFfm to measure insulin resistance in morbid obesity. Obes Surg. 2006;16:549–53.CrossRefPubMed
22.
Zurück zum Zitat Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.PubMed Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.PubMed
23.
Zurück zum Zitat Warensjö E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis. 2006;16:128–36.CrossRefPubMed Warensjö E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis. 2006;16:128–36.CrossRefPubMed
24.
Zurück zum Zitat Abadie JM, Malcom GT, Porter JR, et al. Dehydroepiandrosterone alters Zucker rat soleus and cardiac muscle lipid profiles. Exp Biol Med (Maywood). 2001;226:782–9. Abadie JM, Malcom GT, Porter JR, et al. Dehydroepiandrosterone alters Zucker rat soleus and cardiac muscle lipid profiles. Exp Biol Med (Maywood). 2001;226:782–9.
25.
Zurück zum Zitat Gomez FE, Miyazaki M, Kim YC, et al. Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Biochemistry. 2002;41:5473–82.CrossRefPubMed Gomez FE, Miyazaki M, Kim YC, et al. Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Biochemistry. 2002;41:5473–82.CrossRefPubMed
26.
Zurück zum Zitat Hernández-Morante JJ, Larqué E, Luján JA, et al. N-6 from different sources protect from metabolic alterations to obese patients: a factor analysis. Obesity (Silver Spring). 2009;17:452–9.CrossRef Hernández-Morante JJ, Larqué E, Luján JA, et al. N-6 from different sources protect from metabolic alterations to obese patients: a factor analysis. Obesity (Silver Spring). 2009;17:452–9.CrossRef
27.
Zurück zum Zitat Powell DJ, Turban S, Gray A, et al. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J. 2004;382:619–29.CrossRefPubMed Powell DJ, Turban S, Gray A, et al. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J. 2004;382:619–29.CrossRefPubMed
28.
Zurück zum Zitat Straczkowski M, Kowalska I, Nikolajuk A, et al. Relationship between insulin sensitivity and sphingomyelin signalling pathway in human skeletal muscle. Diabetes. 2004;53:1215–21.CrossRefPubMed Straczkowski M, Kowalska I, Nikolajuk A, et al. Relationship between insulin sensitivity and sphingomyelin signalling pathway in human skeletal muscle. Diabetes. 2004;53:1215–21.CrossRefPubMed
29.
Zurück zum Zitat Field CJ, Ryan EA, Thomson AB, et al. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem. 1990;265:11143–50.PubMed Field CJ, Ryan EA, Thomson AB, et al. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem. 1990;265:11143–50.PubMed
30.
Zurück zum Zitat Grunfeld C, Baird KL, Kahn CR. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun. 1981;103:219–26.CrossRefPubMed Grunfeld C, Baird KL, Kahn CR. Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun. 1981;103:219–26.CrossRefPubMed
31.
Zurück zum Zitat Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids. 2005;72:343–50.CrossRefPubMed Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids. 2005;72:343–50.CrossRefPubMed
32.
Zurück zum Zitat Sjögren P, Sierra-Johnson J, Gertow K, et al. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia. 2008;51:328–35.CrossRefPubMed Sjögren P, Sierra-Johnson J, Gertow K, et al. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia. 2008;51:328–35.CrossRefPubMed
33.
Zurück zum Zitat Webb SJ, Geoghegan TE, Prough RA, et al. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev. 2006;38:89–116.CrossRefPubMed Webb SJ, Geoghegan TE, Prough RA, et al. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev. 2006;38:89–116.CrossRefPubMed
34.
Zurück zum Zitat Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53 Suppl 1:S43–50.CrossRefPubMed Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53 Suppl 1:S43–50.CrossRefPubMed
35.
Zurück zum Zitat Karbowska J, Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem Pharmacol. 2005;70:249–57.CrossRefPubMed Karbowska J, Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem Pharmacol. 2005;70:249–57.CrossRefPubMed
36.
Zurück zum Zitat Hernandez-Morante JJ, Milagro F, Gabaldon JA, et al. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol. 2006;155:593–600.CrossRefPubMed Hernandez-Morante JJ, Milagro F, Gabaldon JA, et al. Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol. 2006;155:593–600.CrossRefPubMed
37.
Zurück zum Zitat Vessby B, Aro A, Skarfors E, et al. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes. 1994;43:1353–7.CrossRefPubMed Vessby B, Aro A, Skarfors E, et al. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes. 1994;43:1353–7.CrossRefPubMed
38.
Zurück zum Zitat Aldamiz-Echevarria L, Prieto JA, Andrade F, et al. Arachidonic acid content in adipose tissue is associated with insulin resistance in healthy children. J Pediatr Gastroenterol Nutr. 2007;44:77–83.CrossRefPubMed Aldamiz-Echevarria L, Prieto JA, Andrade F, et al. Arachidonic acid content in adipose tissue is associated with insulin resistance in healthy children. J Pediatr Gastroenterol Nutr. 2007;44:77–83.CrossRefPubMed
39.
Zurück zum Zitat Dimopoulos N, Watson M, Sakamoto K, et al. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J. 2006;399:473–81.CrossRefPubMed Dimopoulos N, Watson M, Sakamoto K, et al. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J. 2006;399:473–81.CrossRefPubMed
40.
Zurück zum Zitat Riediger ND, Othman R, Fitz E, et al. Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr. 2008;47:153–60.CrossRefPubMed Riediger ND, Othman R, Fitz E, et al. Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr. 2008;47:153–60.CrossRefPubMed
41.
Zurück zum Zitat Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511–25.CrossRefPubMed Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511–25.CrossRefPubMed
42.
Zurück zum Zitat Pérez-de-Heredia F, Sánchez J, Priego T, et al. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids. 2008;73:1128–36.CrossRefPubMed Pérez-de-Heredia F, Sánchez J, Priego T, et al. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Steroids. 2008;73:1128–36.CrossRefPubMed
43.
Zurück zum Zitat Hernandez-Morante JJ, Perez-de-Heredia F, Lujan JA, et al. Role of DHEA-S on body fat distribution: gender- and depot-specific stimulation of adipose tissue lipolysis. Steroids. 2008;73:209–15.CrossRefPubMed Hernandez-Morante JJ, Perez-de-Heredia F, Lujan JA, et al. Role of DHEA-S on body fat distribution: gender- and depot-specific stimulation of adipose tissue lipolysis. Steroids. 2008;73:209–15.CrossRefPubMed
Metadaten
Titel
Dehydroepiandrosterone-Sulfate Modifies Human Fatty Acid Composition of Different Adipose Tissue Depots
verfasst von
Juan Jose Hernandez-Morante
David Cerezo
Rosa Maria Cruz
Elvira Larque
Salvador Zamora
Marta Garaulet
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 1/2011
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-0064-8

Weitere Artikel der Ausgabe 1/2011

Obesity Surgery 1/2011 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.